出典: meddic


cimetropium bromide

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Preventive effects of oral probiotic on infantile colic: a prospective, randomised, blinded, controlled trial using Lactobacillus reuteri DSM 17938.
  • Savino F1, Ceratto S1, Poggi E2, Cartosio ME3, Cordero di Montezemolo L1, Giannattasio A4.
  • Beneficial microbes.Benef Microbes.2015;6(3):245-51. doi: 10.3920/BM2014.0090.
  • Infants were recruited in four centres in North-West Italy. 138 infants were assessed for eligibility, 113 ones underwent randomisation and 105 completed the study. Newborns aged less than 10 days of life, with gestational age between 37 and 42 weeks, birth weight from 2,500 to 4,300 g and normal ph
  • PMID 25488262
  • Comparison between the Effectiveness of Oral Phloroglucin and Cimetropium Bromide as Premedication for Diagnostic Esophagogastroduodenoscopy: An Open-Label, Randomized, Comparative Study.
  • Yun HW1, Shim KN1, Na SK1, Ryu JI1, Lee MJ1, Song EM1, Kim SE1, Jung HK1, Jung SA1.
  • Clinical endoscopy.Clin Endosc.2015 Jan;48(1):48-51. doi: 10.5946/ce.2015.48.1.48. Epub 2015 Jan 31.
  • BACKGROUND/AIMS: Suppression of gastrointestinal (GI) peristalsis during GI endoscopy commonly requires antispasmodic agents such as hyoscine butylbromide, atropine, glucagon, and cimetropium bromide. This study examined the efficacy of oral phloroglucin for the suppression of peristalsis, its impac
  • PMID 25674526
  • Treatment of esophageal motility disorders based on the chicago classification.
  • Maradey-Romero C1, Gabbard S, Fass R.
  • Current treatment options in gastroenterology.Curr Treat Options Gastroenterol.2014 Dec;12(4):441-55. doi: 10.1007/s11938-014-0032-9.
  • OPINION STATEMENT: The Chicago Classification divides esophageal motor disorders based on the recorded value of the integrated relaxation pressure (IRP). The first group includes those with an elevated mean IRP that is associated with peristaltic abnormalities such as achalasia and esophagogastric j
  • PMID 25263532


  • Cimetropium bromide in the treatment of crisis in infantile colic
  • 鎮痙薬臭化シメトロピウム(DA3177)の上部尿路結石に伴う疼痛に対する第3相臨床試験 : 臭化ブチルスコポラミン錠を対照薬とした二重盲検群間比較試験
  • 大川 順正,森本 鎮義,奥山 明彦,吉岡 俊昭,栗田 孝,板谷 宏彬,小川 暢也,岸本 武利,生駒 文彦,小出 卓生
  • 泌尿器科紀要 43(7), 525-538, 1997-07
  • … 6)「有用」以上の有用率が,D群68.7%, B群60.4%であり,D群はB群に比し,高い有用率が認められたA double-blind study was conducted to evaluate the efficacy, safety and usefulness of cimetropium bromide (DA3177) in the patients with pain caused by upper urinary calculus at a daily dose of 75 mg t.i.d. …
  • NAID 120002156912
  • Reproductive and Developmental Study with Cimetropium Bromide in Rats Dosed Orally During Perinatal and Postnatal Period
  • 松尾 朝紀,本間 征人,勝木 昭次
  • 応用薬理 53(2), 145-155, 1997-02-28
  • NAID 10007370443


Cimetropium bromide is a belladonna derivative. ... quaternary ammonium compounds: Scopolamine · Butylscopolamine · Methylscopolamine · Methylatropine · Fentonium; Cimetropium bromide. Propulsives · primarily dopamine antagonists ...



拡張検索cimetropium bromide



cimetropiumcimetropium bromide

cimetropium bromide」